Tag: Johnson & Johnson

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

Live Aperio ePathology Webinar – Peer Review Through Digital Pathology: The Future is Now?

| September 26, 2014 | 0 Comments

Live Aperio ePathology Webinar Peer Review through Digital Pathology: The future is now? Presented by: Erio Barale-Thomas, Principal Scientist, Johnson & Johnson R&D Overview Peer review is a vital step in pre-clinical drug safety studies. However the overhead of slide shipment and pathologist travel add costs and delays to the process, meaning it takes longer […]

Continue Reading